Skip to main content

Continuous Arteriovenous Hemofiltration (CAVH) and Other Continuous Replacement Therapies: Operational Characteristics and Clinical Use

  • Chapter
Replacement of Renal Function by Dialysis

Abstract

Continuous Arteriovenous Hemofiltration (CAVH) is an extracorporeal therapy that can be used for an extended time. In CAVH electrolytes and other small and medium sized solutes are removed from the patient by ultrafiltration. Simultaneously, the blood volume is reconstituted by the administration of a fluid with an electrolyte composition similar to that of normal plasma. A small filter with a membrane highly permeable to water is used and the patient’s arterial-to-venous pressure gradient is sufficient to move the blood through the extracorporeal circuit.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Henderson LW, Besarab A, Michaels A, Bluemle L Jr: Blood purification by ultrafiltration and fluid replacement (Dialfiltration). Trans Am Soc Artif Intern Organs 13: 216, 1967

    Google Scholar 

  2. Silverstein ME, Ford CA, Lysaght MJ, Henderson LW: The treatment of intractable fluid overload. N Engl J Med 291: 747, 1974

    Article  PubMed  CAS  Google Scholar 

  3. Kramer P, Wigger W, Rieger J, Matthaei D, Scheler F: Arteriovenous hemofiltration: A new and simple method for treatment of overhydrated patients resistant to diuretics. Klin Wochenschr 55: 1121, 1977

    Article  PubMed  CAS  Google Scholar 

  4. Kramer P, Kaufhold C, Grone HJ, Wigger W, Rieger J: Management of anurie intensive-care patients with arteriovenous hemofiltration. Int J Artif Organs 3: 255, 1980

    Google Scholar 

  5. Lauer A, Saccaggi A, Ronco C, Belledonne M, Glabman S, Bosch JP: Continuous arteriovenous hemofiltration in the critically ill patient. Ann Intern Med 99: 455, 1983

    PubMed  CAS  Google Scholar 

  6. Mault JR, Bartlett RH, Dechert RE, Clark SF, Swartz RD: Starvation: A major contribution to mortality in acute renal failure? Trans Am Soc Artif Intern Organs 29: 390, 1983

    PubMed  CAS  Google Scholar 

  7. Lieberman KV, Nardi L, Bosch JP: Treatment of acute renal failure in an infant using continuous arteriovenous hemofiltration J Pediatr 106: 646, 1985

    Article  PubMed  CAS  Google Scholar 

  8. Paganini EP, Nakamoto S: Continuous slow ultrafiltration in oliguric acute renal failure. Trans Am Soc Artif Intern Organs 26: 201, 1980

    PubMed  CAS  Google Scholar 

  9. Lauer A, Alvis RC, Avram MM: Hemodynamic consequences of continuous arteriovenous hemofiltration (CAVH) in intractable fluid overload, in CAVH, edited by La Greca G, Fabris A, Ronco C, Milan, Wichtig Editore, 1986, p 227

    Google Scholar 

  10. Magilligan DJ: Effect of ultrafiltration on lung water.Proc Third Int Symposium on Acute Continuous Renal Replacement Therapy, Fort Lauderdale, FL 3: 161, 1987

    Google Scholar 

  11. Paganini EP, Suhoza K, Swann S: Continuous renal replacement therapy in patients with acute renal dysfunction undergoing intraaortic balloon pump and/or left ventricular device support. Trans Am Soc Artif Intern Organs 32: 414, 1986

    CAS  Google Scholar 

  12. Coraim F, Wolner E: Management of cardiac surgery patients with continuous arteriovenous hemofiltration. in Int Conf on CAVH, Aachen. Karger, Basel 1985

    Google Scholar 

  13. Lysaght M, Boggs D, Ritger P, Howard DD, Jensen JJ: Membranes and transport phenomena in CAVH and CAVHD. in CAVH, edited by La Greca G, Fabris A, Ronco C, Milan, Wichtig Editore, 1986, p 77

    Google Scholar 

  14. Göhl H, Konstantin P, Gulberg CA: Hemofiltration membranes. Contr Nephrol 32: 20, 1982

    Google Scholar 

  15. Pappenheimer JR: Passage of molecules through capillary walls. Physiol Rev 33: 387, 1953

    PubMed  CAS  Google Scholar 

  16. Kaplan A, Longnecker R, Folbert VW: Continuous arteriovenous hemofiltration: A report of six month’s experience. Ann Intern Med 100: 358, 1984

    PubMed  CAS  Google Scholar 

  17. Chang RL, Ueki IF, Troy JL, Deen WM, Robertson CR, Brenner BM: Permselectivity of the capillary wall to macromolecules II. Experimental studies in the rat using neutral dextran. Biophys J 15: 887, 1975

    Article  PubMed  CAS  Google Scholar 

  18. Golper TA, Wedel SK, Kaplan AA, Saad AM, Donta S, Paganini EP: Drug removal during continuous arteriovenous hemofiltration: theory and clinical observation. Int J Artif Organs 8: 307, 1985

    PubMed  CAS  Google Scholar 

  19. Golper TA: Continuous arteriovenous hemofiltration in acute renal failure. Am J Kidney Dis 6: 373, 1985

    PubMed  CAS  Google Scholar 

  20. Golper TA: Drug removal during continuous renal replacement therapies in acute renal failure. Proc Third Int Symposium on Acute Continuous Renal Replacement Therapy, Fort Lauderdale, FL 3: 135, 1987

    Google Scholar 

  21. Bennett WM, Aronoff GR, Morrison G, Golper TA: Drug prescribing in renal failure: Dose guidelines for adults. Am J Kidney Dis 3: 155, 1985

    Google Scholar 

  22. Mäher JF, Lapierre L, Schreiner GE, Geiger M, Westervelt FB: Regional heparinization for hemodialysis. N Eng J Med 268: 451, 1963

    Article  Google Scholar 

  23. Pinnick RV, Wiegmann TB, Diederich DA: Regional citrate anticoagulation for hemodialysis in patients at high risk for bleeding. N Eng J Med 308: 258, 1983

    Article  CAS  Google Scholar 

  24. Zusman RM, Rubin RH, Cato A: Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. N Eng J Med 304: 934, 1981

    Article  CAS  Google Scholar 

  25. Josefowicz M, Josefowicz J: New approaches to anticoagulation with heparin-like biomaterials. asaio J 8: 218, 1985

    Google Scholar 

  26. Hirsch J, Ofosu F, Buchanan M: Rationale behind the development of low molecular weight heparin derivatives. Semin Thromb Hemost 11: 13, 1985

    Article  Google Scholar 

  27. Olbricht C, Mueller C, Schurek HJ, Stolte H: Treatment of acute renal failure in patients with multiple organ failure by continuous spontaneous hemofiltration. Trans Am Soc Artif Intern Organs 28: 23, 1982

    Google Scholar 

  28. Kramer P, Boehler J, Kehr A, Groene HJ, Schader R, Mattahaei D, Scheler F: Intensive care potential of continuous arteriovenous hemofiltration. Trans Am Soc Artif Intern Organs 28: 28, 1982

    PubMed  CAS  Google Scholar 

  29. Misler S: Long term ultrafiltration as a treatment of refractory congestive heart failure. NY State J Med 10: 518, 1984

    Google Scholar 

  30. Morgan SH, Mansell MA, Thompson TD: Fluid removal by hemofiltration in diuretic resistant cardiac failure. Br Heart J 54: 218, 1985

    Article  PubMed  CAS  Google Scholar 

  31. Lauer A, Alvis R, Beal A, Avram M: Hemodynamic consequences of continuous arteriovenous hemofiltration in intractable fluid overload. (Abstract) Kidney Int 29: 218, 1986

    Google Scholar 

  32. Kaufman A, Levitt M: The effect of diuretics on systemic and renal hemodynamics in patients with renal insufficiency. Am J Kidney Dis 5: A71, 1985

    PubMed  CAS  Google Scholar 

  33. Raimondi F, Bianchi T, Emmi V, Braschi A, Iotti G, Bobbio Pallavicini F, Tosi P, Fischetti M, Galli F, Villa S: Use of continuous arteriovenous hemofiltration (CAVH) in lactic acidosis: A case report, in CAVH, edited by La Greca G, Fabris A, Ronco C, Milan, Wichtig Editore, 1986, p 135

    Google Scholar 

  34. Ronco C, Brendolan S, Bragantini L, Chiaramonti S, Dell’Aquila R, Fabris A, Feriani M, Milan M, La Greca G: Arteriovenous hemodiafiltration: A combined therapy for acute renal failure in the hypercatabolic patients, in CAVH, edited by La Greca G, Fabris A, Ronco C, Milan, Wichtig Editore, 1986, p 171

    Google Scholar 

  35. Geronemus R, von Albertini B, Glabman S, Lysaght M, Khan T, Bosch JP: Enhanced molecular clearance in hemofiltration. Proc Clin Dial Transplant Forum 8: 147, 1978

    PubMed  CAS  Google Scholar 

  36. Kaplan AA: Predilution vs postdilution for continuous arteriovenous hemofiltration. Trans Am Soc Artif Intern Organs 31: 28, 1985

    PubMed  CAS  Google Scholar 

  37. Kaplan AA, Longnecker R, Folkert VW: Suction-assisted continuous arteriovenous hemofiltration. Trans Am Soc Artif Intern Organs 24: 408, 1983

    Google Scholar 

  38. Kaplan AA: Enhanced Efficiency During CAVH: Clinical trials with predilution and vacuum suction, in CAVH, edited by La Greca G, Fabris A, Ronco C, Milan, Wichtig Editore, 1986, p 49

    Google Scholar 

  39. Geronemus R, Schneider N: Continuous arteriovenous hemodialysis: A new modality for treatment of acute renal failure: Trans Am Soc Artif Intern Organs 30: 610, 1984

    PubMed  CAS  Google Scholar 

  40. Ing TS, Daugirdas JT, Bregman H, Leehey DJ: Continuous arteriovenous hemodialysis. Int J Artif Organs 8: 117, 1985

    PubMed  CAS  Google Scholar 

  41. Sigler M, Teehan BP: Solute transport in slow continuous arteriovenous hemodialysis: An improved method for treating acute renal failure. Proc Third Int Symposium on Acute Continuous Renal Replacement Therapy, Fort Lauderdale, FL 3: 78, 1987

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers

About this chapter

Cite this chapter

Bosch, J.P., Ronco, C. (1989). Continuous Arteriovenous Hemofiltration (CAVH) and Other Continuous Replacement Therapies: Operational Characteristics and Clinical Use. In: Maher, J.F. (eds) Replacement of Renal Function by Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1087-4_15

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-1087-4_15

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6979-3

  • Online ISBN: 978-94-009-1087-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics